News
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...
This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students...
In an open statement, civil society groups, scientists, and academics are challenging the democratic legitimacy of any conclusions or policy...
One of the greatest scandals in modern science began with a late-2010s advertisement for HIV-positive couples looking to have children...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez.
The New...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said...
A two-and-a-half-year-old girl shows no signs of a rare genetic disorder, after becoming the first person to be treated for...
California scientists took what looked like an $800 million hit last week in their efforts to develop revolutionary treatments and...
On a sunny September day in 2023, scientists at CRISPR Therapeutics invited me to peer through their microscopes. Through the...